cdifffoundation.org
C. difficile infection – Prevention – Da Volterra presents promising results of DAV-132 compound
* In The News 13 May 2014 * Da Volterra, a leading biopharmaceutical company in the field of bacterial resistance, announces today very promising new results about DAV132 in the prevention of the s…